Global Media Strategies -- Your Brand, Your Audience

Dean Mitchell appointed to Talecris Board of Directors

December 18, 2009 By: NCTechNews Category: Biopharmaceutical

(Research Triangle Park, N.C.) Talecris Biotherapeutics Holdings Corp. (NASDAQ:TLCR) today announced that Dean Jonathan Mitchell has been appointed to its board of directors. Mitchell’s appointment brings the number of Talecris board members to ten. Mitchell is a seasoned pharmaceutical executive with a proven record of building businesses and creating shareholder value. His extensive industry experience includes commercial management, clinical development, global product launches, executive management and strategic acquisitions. He has served in executive leadership positions at Alpharma Inc., Guilford Pharmaceuticals Inc., Bristol-Myers Squibb and GlaxoSmithKline.

“Dean brings to Talecris a diverse background in the pharmaceutical industry, which complements the strength of our existing board,” said Lawrence D. Stern, chairman and chief executive officer of Talecris. “We are pleased to welcome Dean to our board of directors, and we look forward to benefiting from his expertise.” Mitchell will be a member of the compensation subcommittee of the board.

Mitchell most recently served as president and CEO at Alpharma Inc., a global specialty pharmaceutical company, and was also appointed to its board of directors. Alpharma Inc. was acquired by King Pharmaceuticals, Inc. in December 2008, and Mr. Mitchell ceased to be a director of Alpharma Inc. in December 2008. Prior to his tenure at Alpharma, Mitchell was president and CEO of Guilford Pharmaceuticals Inc., from December 2004 until its acquisition by MGI Pharma Inc., in October 2005. Mitchell was at Bristol-Myers Squibb from 2001 until 2004 in several roles, including president, international pharmaceuticals; president U.S. primary care; and vice president, strategy. He also spent 15 years at Glaxo SmithKline and its predecessor companies, most recently as senior vice president, clinical development and product strategy from 1999 to 2001, and prior to that as vice president and general manager of specialty divisions, strategic planning and business development from 1995 to 1999. He received his MBA from City University Business School (London, UK) and his B.Sc. in Biology from Coventry University, UK.

Talecris Biotherapeutics is a global biotherapeutic and biotechnology company that discovers, develops and produces critical care treatments for people with life-threatening disorders in a variety of therapeutic areas including immunology, pulmonology, neurology and hemostasis.

Comments are closed.

← WingSwept promotes staff member to conquer another vertical
Liquidia Technologies receives $3 million in funding →

  • Controlling Quality
    An RTP firm is gaining international notoriety as a leader in analytical instrumentation for the pharmaceutical and chemical manufacturing industries, sharing innovative solutions to evolving pharmaceutical and chemical manufacturing challenges, presenting on emerging multi-variant approaches to obtaining immediate, unambiguous results from drug product samples at a recent major international tradeshow.

    Portable Power
    Alternative energy solutions provider INI Power Systems, Inc. recently marked its ten-year anniversary by unveiling the innovative new Trinity™ series of portable alternative energy hybrid solutions at two major events catering to the defense and emergency first responder marketplaces, with attendees searching for reliable, flexible power systems with multiple applications.

    EV Innovation
    Morrisville-based green transportation pioneer Evatran™ recently hosted a demonstration of its Plugless Power™ hands-free electric vehicle (EV) charging system, showcasing cost savings and convenience of EV usage in residential, commercial and public applications.

    guide to success
    Entrepreneurs now have a workbook to guide them through successful implementation of business building blocks thanks to a new goal-setting toolkit for personal and professional success available at no charge from a Cary-based international strategic business consultant.

    Packaging Cures
    RTP-based advertising and branding firm The Marketing Machine helped overcome the issue of illiteracy among medical patients in Ghana, South Africa in designing packaging for the only manufacturer of anti-retroviral drugs in the region, creating individual icons and colors to help patients understand which drugs they needed, regardless of their ability to read.

    Broadband Stimulus
    Two grants funded by the American Recovery and Reinvestment Act are being used by MCNC to expand broadband connectivity and services throughout North Carolina and create more than 1,000 engineering and construction jobs, the organization said.

  • Recent Headlines

















free web site traffic and promotion